male patients diagnosed as having uncomplicated gonococcal urethritis with one of two regimens. They were divided into two groups and randomly assigned to treatment with either 2 g spectinomycin administered intramuscularly (group A) or 300 mg rosoxacin by mouth (group B). Of 187 isolates tested for the production of P-lactamase, 101 (54%) were penicillinase producing Neisseria gonorrhoeae (PPNG) strains. All 81 cases followed in group A (spectinomycin) were cured, compared with 88' 5 % (77 out of 87) of the patients followed in group B (rosoxacin).
Introduction
Patients The difference between the cure rates in group A (spectinomycin) and group B (rosoxacin) was significant (x2 = 9-89; p<0 01). In group B (rosoxacin) there was no difference between the results of treatment of the patients infected by PPNG and non-PPNG strains (X2 = 0 02; p>0 01).
The side effects encountered among the patients who took rosoxacin in our study were considered to be mild, and all the patients recovered spontaneously. We conclude that the tolerance to this antimicrobial agent was good. 
